R.PR
REGISTERED-PRINCIPAL REGISTER
15/03/2022
Voltar para busca
Dado oficial do USPTO
EBALANCE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
15/03/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 10
Data de depósito
11/12/2017
Data de registro
15/03/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/03/2022
Última transação
15/03/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Carson City, NV, US
Examinador
CORWIN, KEVIN SCOTT
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Cell MedX Corp.
Representantes
Paul A. McLean, Esq. GREENBERG TRAURIG, LLP
Classificação técnica
Classes Nice
Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Computer software and application software for operating microcurrent devices for the monitoring and treatment of symptoms of diabetesrehabilitation of pain and injuriespain reliefdisease treatment and prevention; computer software and application software for operating transcutaneous electrical nerve stimulation deviceselectrical muscle stimulation devicesmicrocurrent electrotherapy devices; computer-controlled system for applying electrical microcurrent to the skincomprising computer hardware and computer software for operating microcurrent devices for the monitoring and treatment of symptoms of diabetesrehabilitation of pain and injuriespain reliefdisease treatment and prevention; computer-controlled system for applying electrical microcurrent to the skincomprising computer hardware and computer software for operating transcutaneous electrical nerve stimulation deviceselectrical muscle stimulation devicesmicrocurrent electrotherapy devices
Classe 10
Transcutaneous electrical nerve stimulators for the treatment of the symptoms of diabetes; electrical muscle stimulators for the treatment of the symptoms of diabetes; microcurrent electrotherapy stimulators for the treatment of the symptoms of diabetes; transcutaneous electrical nerve stimulation devices for medical purposes; electrical muscle stimulation devices for medical purposes; microcurrent electrotherapy devices for medical purposes; transcutaneous electrical nerve stimulation apparatus for medical purposes; electrical muscle stimulation apparatus for medical purposes; microcurrent electrotherapy apparatus for medical purposes; medical devicesmicrocurrent devices for the monitoring and treatment of symptoms of diabetesrehabilitation of pain and injuriespain reliefdisease treatment and prevention; medical devicesmicrocurrent devices for general health and well-being; Medical apparatus and devices for use in microcurrent therapy and treatment; transcutaneous electrical nerve stimulators used for medicalmedical rehabilitation and physical therapy purposes; electrical muscle stimulators used for medicalmedical rehabilitation and physical therapy purposes; microcurrent electrotherapy stimulators used for medicalmedical rehabilitation and physical therapy purposes; computer controlled biofeedback devices and bioresonance devices in the nature of sensors that generate microcurrents for medicalmedical rehabilitation and physical therapy purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
10/02/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/02/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
11/01/2022
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
11/01/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
16/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/09/2021
PUBO
PUBLISHED FOR OPPOSITION
21/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/09/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/08/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/08/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/08/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
20/04/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
20/04/2021
CNSI
SUSPENSION INQUIRY WRITTEN
20/04/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
20/10/2020
GNSL
LETTER OF SUSPENSION E-MAILED
20/10/2020
CNSL
SUSPENSION LETTER WRITTEN
20/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/10/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/10/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/10/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
17/04/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
17/04/2020
CNSI
SUSPENSION INQUIRY WRITTEN
17/04/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
16/10/2019
GNSL
LETTER OF SUSPENSION E-MAILED
16/10/2019
CNSL
SUSPENSION LETTER WRITTEN
16/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/10/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/10/2019
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
16/04/2019
GNSI
INQUIRY TO SUSPENSION E-MAILED
16/04/2019
CNSI
SUSPENSION INQUIRY WRITTEN
16/04/2019
ALIE
ASSIGNED TO LIE
09/04/2019
DOCK
ASSIGNED TO EXAMINER
12/12/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
21/09/2018
GNSL
LETTER OF SUSPENSION E-MAILED
21/09/2018
CNSL
SUSPENSION LETTER WRITTEN
21/09/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/09/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/09/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/09/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/04/2018
GNRT
NON-FINAL ACTION E-MAILED
03/04/2018
CNRT
NON-FINAL ACTION WRITTEN
03/04/2018
DOCK
ASSIGNED TO EXAMINER
22/03/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/12/2017
NWAP
NEW APPLICATION ENTERED
14/12/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EBALANCE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.